A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?
Recent research reveals five distinct subtypes of diabetes, offering a nuanced understanding of this chronic condition. This ...
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...
Blood sugar management is a central component of diabetes care. One of the most crucial tools for managing diabetes is the ...
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
Insulin has long been the typical pharmacological go-to agent for gestational diabetes, the researchers pointed out, but oral ...
A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...
A groundbreaking discovery has unveiled a promising avenue in diabetes research. Scientists have identified a novel enzyme, SNO-CoA-assisted nitrosylase (SCAN), which plays a crucial role in ...